Short Summary
Google’s IPR against patent 8116749 resulted in a mixed decision: five claims were held unpatentable over Perttila and Insolia, while four claims remained patentable because the obviousness challenge failed.
Detailed Summary
In IPR2020-00933, Google challenged claims 19‑23, 25, 26, 28, and 29 of U.S. Patent No. 8116749. The Board instituted the review on all grounds and evaluated two statutory grounds of obviousness under 35 U.S.C. § 103(a). For claims 19‑23, the Board found that Perttila’s short‑range communication system combined with Insolia’s loyalty‑program teachings rendered the claims obvious, leading to a finding of unpatentability. For claims 25, 26, 28, and 29, the Board concluded that the petitioner’s evidence was insufficient to show that Perttila and Davis taught the required “name of an entity or object” limitation, and therefore upheld those claims. The final written decision thus delivers a mixed outcome, cancelling five claims and leaving four intact.
Practitioner Note
This case demonstrates the evidentiary and procedural standards applied in patent matters before local courts. Understanding the court's reasoning in Google LLC vs Secure Communication Technologies, LLC is valuable context for structuring arguments or assessing risk in similar proceedings.
Related Cases
SAMSUNG ELECTRONICS CO., LTD. et al.vsOMNI MEDSCI, INC.
Apple has filed an IPR petition seeking to invalidate Omni MedSci’s ’484 wearable health‑monitoring patent. The petition argues the claims are obvious over a combination of five prior‑art references and requests that the Board institute the trial.
PacifiCorp et al.vsMES, Inc.
Energy utilities settled their PTAB disputes with BirchTech, prompting the Board to terminate the IPRs for the settling parties and keep the settlement agreements confidential. Remaining petitioners stay in the proceeding.
Google LLCvsDialect LLC
Google has filed a petition for Director Review seeking to overturn the PTAB’s denial of institution in an IPR against Dialect’s voice‑command patent. The petitioner contends the Board misinterpreted the Coffman reference and ignored unrebutted expert testimony.
Merck Sharp & Dohme LLCvsHalozyme, Inc. et al.
Merck challenges Halozyme’s broad PH20 hyaluronidase patent, asserting lack of written description, enablement, and obviousness. The petition seeks to invalidate all 40 claims.
Microsoft CorporationvsEyesMatch Ltd.
The PTAB upheld all claims of the patent in this final written decision after rejecting multiple grounds of obviousness (103). The Board adopted specific claim constructions for 'mirror-mimicking' and 'varying rate,' finding the petitioner failed to meet its burden of proof.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.
Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.